TABLE 4

Literature overview nutritional components and their effect on the immune system via TLRs

ReceptorNutritional ActivatorConcentration and Mode of AdministrationType of StudyModelStimulant/Disease ModelEffectReference
TLR2Normal or Western-like rodent dietAd libitumIn vivoWT and TLR2/4 double-KO C57BL6Crossfostering and TLR4 specific inhibitor TAK-242Maternal Western diet caused neonatal toxicity and inflammation, possibly related to long-chain fatty acids and SFAs in mother milk. TLR2/4 deletion rescues the neonatal toxicity(Du et al., 2012)
Free fatty acids500 µMIn vitro/ex vivoRAW264.7 cells and BMDC from WT and TLR2/4 double-KO C57BL/6 miceRAW264.7 cells were treated with siRNA-TLR2/4Increase in proinflammatory cytokines(Nguyen et al., 2007)
β2→1-fructan1 or 100 µg/mlIn vitroHuman PBMC, THP-1 cells, and TLR2 reporter cell linesElevated IL-10/IL-12 protein levels(Vogt et al., 2013)
β2→1-fructan100 mg/lIn vitroT84 cellsPhorbol 12-myrestare 13-acetate and TLR2 blocking antibodyImprovement of intestinal epithelial barrier function(Vogt et al., 2014)
TLR4FOS, inulin, GOS, and goat milk oligosaccharides0.005 –5 g/lIn vitro/ex vivoHuman peripheral blood monocytes, monocytes and lymphocytes from Wistar rats, and splenocytes from WT and TLR4−/− C57BL/6J miceLPS, concanavalin A, and MAPK inhibitorsNDOs generally evoked cytokine release by splenocytes and monocytes, possibly via activation of TLR4 and engagement of NF-ĸB and MAPK pathways NF-ĸB(Capitán-Cañadas et al., 2014)
Normal or Western-like rodent dietAd libitumIn vivoWT and TLR2/4 double-KO C57BL6Crossfostering and TLR4-specific inhibitor TAK-242Maternal Western diet caused neonatal toxicity and inflammation, possibly related to long-chain fatty acids and SFAs in mother milk. TLR2/4 deletion rescues the neonatal toxicity(Du et al., 2012)
Sodium palmitate and laurate100–500 µMIn vitroRAW 264.7 cells, immortalized MyD88−/− macrophages, and HEK293T cellsBovine serum albumin and polymyxin B and TLR4-specific inhibitor TAK-242Induction of COX-2 and TNF-α(Huang et al., 2012)
Sialyl(α2,3)lactose25 mM in diet or 3 mg oral gavageIn vivoSt3gal4−/−, IL10−/−, St3gal4−/−;IL10−/− and TLR4−/− C57BL/J6 miceCrossfostering
Spontaneous chronic intestinal inflammation
Early onset and exacerbation of colitis symptoms, increased proinflammatory cytokines, proinflammatory monocytes, Th1 and Th17 cells(Kurakevich et al., 2013)
Lauric acid50, 75, or 100 µMIn vitroRAW264.7 and 293T cells transfected with TLR4 and MD2Dominant-negative mutant of TLR4, MyD88, IRAK-1, TRAF6, or IĸBα.
I3K inhibitor (LY294002) or a dominant-negative mutant of PI3K or AKT
Activation of TLR4 and signaling pathways involving MyD88/IRAK/TRAF6 and PI3K/AKT(Lee et al., 2003)
Short-chain GOS/long-chain FOS5 mg/mlIn vitroHuman monocyte–derived DCsLPS, Bifidobacterium breve, and TLR4-specific antagonistInduction of IL-10 secretion of (Bifidobacterium breve–stimulated) DCs(Lehmann et al., 2015)
Palmitic acid50–300 µMIn vitroHuman monocyte–derived DCs and recombinant TLR4/MD2 HeLa cellsUpregulation of DC costimulatory factors CD86 and CD83 and expression of IL-1β by interacting with TLR4/MD-2(Nicholas et al., 2017)
Free fatty acids500 µMIn vitro/ex vivoRAW264.7 cells and BMDC from WT and TLR2/4 double-KO C57BL/6 miceRAW264.7 cells were treated with siRNA-TLR2/4Increase in proinflammatory cytokines(Nguyen et al., 2007)
Goat milk oligosaccharides, inulin, GOS, and FOS5 mg/mlIn vitro/ex vivoIEC18, HT29, Caco-2 and Caco‐2/TC7 cells and colon cells from WT and TLR4 KO C57BL/6J miceSpecific inhibitors of NF-κB and MAPK pathways, shRNA specific for MyD88 and TLR4 for gene knockdownNDOs stimulated cytokine production in intestinal epithelial cells (e.g., CXCL-1 and MCP-1)(Ortega-González et al., 2014)
High-fat diet
Palmitate and oleate
Not specified (diet)
200 or 400 µM (in vitro)
In vivo/in vitroWT and TLR4−/− C57BL6/J mice, ob/ob and db/db mice. RAW264.7 cells and 293T 3T3-L1 adipocytes, isolated mouse adipocytes, adipose tissue, and peritoneal macrophages from TLR4−/− miceDiet-induced obesity siRNA-TLR4Diet-induced inflammation and insulin resistance, increased TLR4 expression in adipose tissue of obese/diabetic mice.
Activation of TLR4 signaling, stimulation of cytokine expression (e.g., TNF-α, IL-6)
(Shi et al., 2006)
Palmitate100-200 µMIn vitro/ex vivoCoculture of 3T3-L1 and RAW264.7, Ba/F3,
or TLR4 mutant peritoneal macrophages of C3H/HeJ or C3H/HeN mice
TNF-α, LPSRole of TLR4/NF-κB pathway in SFA-induced inflammatory changes(Suganami et al., 2007)
  • HEK, Human Embryonic Kidney; IEC, intestinal epithelial cell line; MAPK = Mitogen-Activated Protein Kinase; shRNA, short hairpin RNA.